UK Ginkgo Dementia Trial Follows “Promising” Cochrane Review Findings
This article was originally published in The Tan Sheet
Executive Summary
A 400-person trial to evaluate ginkgo biloba in the treatment of early dementia is in the protocol-planning stages and should be completed by December 2005
You may also be interested in...
Ginkgo Study Shows “No Measurable Benefit” For Memory, Cognition
Daily doses of ginkgo biloba for six weeks resulted in "no significant difference for any outcome measure" versus placebo in approximately 200 adults over age 60 with healthy cognitive function in a study published in the Aug. 21 Journal of the American Medical Association.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands